Evidence map›Paper›PMID 36114154›Full record

SynthesisJournal of medical virology2023

Prevalence and factors related to COVID-19 vaccine hesitancy and unwillingness in Canada: A systematic review and meta-analysis.

Jude Mary Cénat, Pari-Gole Noorishad, Seyed Mohammad Mahdi Moshirian Farahi, Wina Paul Darius, Aya Mesbahi El Aouame, Olivia Onesi, Cathy Broussard, Sarah E Furyk, Sanni Yaya, Lisa Caulley and 3 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jude Mary CénatSchool of Psychology, University of Ottawa, Ontario, Canada.ORCID 0000-0003-3628-6904
Pari-Gole NoorishadSchool of Psychology, University of Ottawa, Ontario, Canada.
Seyed Mohammad Mahdi Moshirian FarahiDepartment of Psychology, Carleton University, Ottawa, Ontario, Canada.ORCID 0000-0002-2144-9515
Wina Paul DariusSchool of Psychology, University of Ottawa, Ontario, Canada.
Aya Mesbahi El AouameSchool of Psychology, University of Ottawa, Ontario, Canada.
Olivia OnesiSchool of Psychology, University of Ottawa, Ontario, Canada.
Cathy BroussardSchool of Psychology, University of Ottawa, Ontario, Canada.
Sarah E FurykSchool of Psychology, University of Ottawa, Ontario, Canada.
Sanni YayaSchool of International Development and Global Studies, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-4876-6043
Lisa CaulleyInterdisciplinary Centre for Black Health, University of Ottawa, Ontario, Canada.
Marie-Hélène ChomienneInterdisciplinary Centre for Black Health, University of Ottawa, Ontario, Canada.
Josephine EtowaInterdisciplinary Centre for Black Health, University of Ottawa, Ontario, Canada.
Patrick R LabelleLibrary, University of Ottawa, Ontario, Canada.

Funding

CIHR 469050
6 · The paper itself

Abstract

This systematic review and meta-analysis examined the prevalence and factors associated with vaccine hesitancy and vaccine unwillingness in Canada. Eleven databases were searched in March 2022. The pooled prevalence of coronavirus disease 2019 (COVID-19) vaccine hesitancy and unwillingness was estimated. Subgroup analyses and meta-regressions were performed. Out of 667 studies screened, 86 full-text articles were reviewed, and 30 were included in the systematic review. Twenty-four articles were included in the meta-analysis; 12 for the pooled prevalence of vaccine hesitancy (42.3% [95% CI, 33.7%-51.0%]) and 12 for vaccine unwillingness (20.1% [95% CI, 15.2%-24.9%]). Vaccine hesitancy was higher in females (18.3% [95% CI, 12.4%-24.2%]) than males (13.9% [95% CI, 9.0%-18.8%]), and in rural (16.3% [95% CI, 12.9%-19.7%]) versus urban areas (14.1% [95%CI, 9.9%-18.3%]). Vaccine unwillingness was higher in females (19.9% [95% CI, 11.0%-24.8%]) compared with males (13.6% [95% CI, 8.0%-19.2%]), non-White individuals (21.7% [95% CI, 16.2%-27.3%]) than White individuals (14.8% [95% CI, 11.0%-18.5%]), and secondary or less (24.2% [95% CI, 18.8%-29.6%]) versus postsecondary education (15.9% [95% CI, 11.6%-20.2%]). Factors related to racial disparities, gender, education level, and age are discussed.

Indexed as

COVID-19COVID-19 VaccinesCanadaDatabases, FactualFemaleHumansMalePrevalenceCOVID-19 VaccinesCOVID-19 vaccinesystematic reviewvaccine hesitancyvaccine willingness

Identifiers

PMID36114154
PMCPMC9538578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.